Alterations in the synthesis of thromboxane A 2 (TxA 2 ) and prostacyclin have been implicated in the development of atherosclerosis. We measured the amounts of the degradation products of these substances, TxBj and 6-oxo-prostaglandin F la (6-oxo-PGFjJ, respectively, as well as PGE?, that were synthesized by slices and the lumlnal surfaces of aortas from rabbits fed either a control diet or a diet supplemented with cholesterol and peanut oil. For these studies, we developed conditions that were designed to minimize the autoinactivation of cyclooxygenase during removal and preparation of the tissue. Pretreatment of aortas with a medium containing ibuprofen and EDTA resulted in an approximately twofold increase in 6-oxo-PGF la production upon subsequent incubation. Despite the increased lipid peroxidation associated with atherosclerotic lesions, we observed no changes in either aortic 6-oxo-PGF la production or in the levels of its major urinary metabolite, 2,3-dinor-6-oxo-PGFi a , after as long as 15 weeks of dietary supplementation with cholesterol and peanut oil. Similarly, synthesis of PGE? by aortic slices and the aortic lumen was the same in cholesterol-fed and control rabbits. In contrast to aortic 6-oxo-PGF 1( , and PGE? synthesis, there was a dramatic 10-fold increase in TxB 2 released from slices of thoracic aorta after 15 weeks on the atherogenic diet This was much greater than the approximately twofold increase in the synthesis of TxB 2 by the luminal surface of the thoracic aorta, suggesting that the primary site of TxB 2 synthesis in the aorta is in the inner part of the blood vessel. Slices of pulmonary artery released more TxBj, 6-oxo-PGF la , and PGFt han did slices from the aortic arch or the middle section of the thoracic aorta in control rabbits. However, the aortic arch was the major site of TxB 2 production in hypercholesterolemic rabbits. It is possible that aortic TxA 2 could contribute to the development of atherosclerosis due to its potent effects on platelets. (Arteriosclerosis and Thrombosis 1991;ll:501-508) P rostacyclin (prostaglandin I 2 [PGI 2 ]) and thromboxane A 2 (TxA 2 ) are important mediators of cardiovascular and platelet function. Because of its potent inhibitory effects on platelet activation, PGI 2 could diminish the accumulation of platelets at the site of atherosclerotic lesions and prevent or impede the progression of the disease. In addition to its effects on platelets, PGI 2 is a potent vasodilator and a systemic vasodepressor.
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1 PGI 2 has a stimulatory effect on cholesteryl ester hydrolase in vascular smooth muscle cells, which could result in a reduction in the accumulation of cholesteryl esters at the site of the lesion.
2 PGI 2 has also been reported to inhibit the release of platelet-derived growth factor from platelets, as well as the release of growth factors from endothelial cells and macrophages. 3 Because of these effects, sustained PGI 2 production by the vascular endothelium, its major site of synthesis, may be an important factor in preventing the onset of atherosclerosis. TxA 2 , which is produced in large amounts by platelets 4 but in only very small amounts by normal blood vessels, is a potent stimulator of platelet aggregation and vasoconstrictor and could enhance the development of atherosclerosis. 5 There is considerable controversy in the literature about the production of PGI 2 by atherosclerotic blood vessels, with several reports indicating considerably diminished production 6 -10 and others reporting unchanged 11 or enhanced 12 -15 production. The major objectives of the present study were to determine whether the atherosclerotic lesions induced by dietary supplementation with cholesterol in rabbits were accompanied by alterations in the synthesis of PGI 2 , TxA 2 , and PGEj by the aorta. We also wanted to ascertain whether this treatment caused changes in the production of PGI 2 and TxA 2 in vivo as assessed by measurement of the major urinary metabolites of these substances.
Methods

Materials
Cholesterol and propyl gallate were purchased from the Aldrich Chemical Co., Milwaukee, Wis. Ibuprofen, papaverine, and butylated hydroxyanisole were obtained from Sigma Chemical Company, St. Louis, Mo, Unlabeled arachidonic acid was purchased from NuChek Prep, Inc., Elysian, Minn., and purified just before use by chromatography on an open column of silicic acid to remove autooxidation products.
6 -O x o [ 5 , 8 , 9 , l l , 1 2 , 1 4 , 1 5 -3 H ] P G F l a , [5, 6, 8, 11, 12, 14, H]PGE 2 , and [5, 6, 8, 9, 11, 12, 14, 15 -H]TxB2 were obtained from New England Nuclear, Lachine, Canada, whereas unlabeled TxBj, PGs, and 2,3-dinor [18, 18, 19, H]TxB 2 were kindly provided by J.E. Pike of The Upjohn Company, Kalamazoo, Mich. 2,3-Dinor-6-oxo-PGF la and 2,3-dinor-6-oxo[8,10,10-HJPGFi,, were prepared as previously described. 16 Antisera to PGE2 and 6-oxo-PGF la were purchased from Advanced Magnetics, Cambridge, Mass, and L. Levine, Brandeis University, respectively. F. Fitzpatrick kindly provided the antiserum to TXB2.
Animals and Diets
Male New Zealand White rabbits (2-2.2 kg) were purchased from La Ferme Lapro Inc., Stukely-Sud, Canada. Rabbits (seven in each group) were fed a daily ration of either rabbit chow (60 g) or rabbit chow (53 g) supplemented with 0.5 g cholesterol, 6 g peanut oil (Planters, Ontario, Canada), 0.5 ml ethyl alcohol, and 0.5 g butylated hydroxyanisole as described in the literature. 17 After 2, 8, or 15 weeks, the rabbits were placed in metabolic cages. Urine was collected on the second day the rabbits were in the cages and was processed for analysis of 2,3-dinor-6-oxo-PGF la and 2,3-dinor-TxB 2 as described below. The treatment described above resulted in low density lipoprotein (LDL) cholesterol levels in plasma of 4.19±0.18 and 4.76±0.67 mg/ml plasma after 8 and 15 weeks, respectively, compared with 0.15 ±0.01 mg/ml plasma in the control group.
Preparation of Blood Vessels
Rabbits were injected with papaverine (4 mg/kg body wt) and heparin (200 units/kg body wt) to minimize the effects of vessel contraction and thrombin formation. 18 Two minutes later, they were killed by inhalation of carbon dioxide. After the thoracic cavity was rapidly opened, the aorta was immediately perfused in situ with Ca 2+ ,Mg
2+
-free modified KrebsRinger-tris(hydroxymethyl)aminomethane (Tris) medium containing 127 mM NaCl, 5 mM KC1, 1.27 mM KH 2 PO 4 , 5.5 mM glucose, 2 mM EDTA disodium salt, 10 ^.M ibuprofen, 10 /iM papaverine, and 15 mM Tris HC1, pH 7.4 (medium A). The aorta and pulmonary artery (PA) were then removed and placed in medium A. The aorta was cut into four pieces as shown in Figure 1 (S 1; T l7 S2, T 2 ), and adhering fatty tissue was removed from the outside. An approximate estimate of the areas of the aorta covered by lesions was obtained independently by visual examination of the four sections from each aorta by two individuals, who estimated the percentage of the total area that was covered by lesions (to the nearest 10%). The areas of sections S 1; T b S 2 , and T 2 covered by lesions were approximately 56%, 38%, 26%, and 14%, respectively, of the total surface area of that section after 8 weeks and 90%, 80%, 54%, and 50%, respectively, after 15 weeks.
Incubation of Slices of Blood Vessels
The aortic arch (S]), the middle section of the thoracic aorta (S 2 ), and the PA were cut into small slices (about 3 mm 2 ). To remove the EDTA, ibuprofen, and papaverine, the slices were washed five times at 0°C with Krebs-Ringer-Tris medium containing 127 mM NaCl, 5 mM KC1, 1.27 mM MgSO 4 , 1.27 mM KH 2 PO 4 , 2.7 mM CaClz, 5.5 mM glucose, and 15 mM Tris HC1, pH 7.4 (medium B). The slices were then incubated for 30 minutes at 37°C in the absence of exogenous fatty acid substrate.
Incubation ofLuminal Surfaces of Aortas With Arachidonic Acid by the Template Method
Sections T! and T 2 of the aorta were placed vertically between two Lucite blocks, one of which contained a small incubation chamber (height, 27 mm; diameter, 10 mm), which allowed the medium to come in contact with only the luminal surface of the aorta. The chamber extended below the aorta, which was mounted on the side, to permit stirring with a magnetic stirring bar during the incubation. 18 The luminal surface (30 mm 2 ) of the aorta was incubated at 37°C for 5 minutes with medium A and then washed for five periods of 5 minutes each with medium B. The aorta was then incubated for 10 minutes at 37°C in the presence of arachidonic acid (25 /u,M).
Measurement of Prostanoids
The amounts of 6-oxo-PGF la , PGEz, and TxBj in the incubation media from slices and the luminal surfaces of aortas were measured by radioimmunoassay. 19 Urinary levels of Z^-dinor-6-oxo-PGF!,, and 2,3-dinorTxB^ were measured as described previously by negative-ion chemical-ionization gas chromatography-mass spectrometry using 2 r 3-dinor-6-oxo[8,10,10-J H]PGF la and 2,3-dinor [18, 18, 19, 19] TxB2 as internal standards. 20 - 21 These analyses were performed using a Hewlett-Packard Model 5985 mass spectrometer (Palo, Alto, Calif.).
Measurement of Low Density Lipoprotein and Total Cholesterol in Aortas
On the morning of the day when the rabbits were to be killed, blood (14 ml) was withdrawn from the ear vein into two tubes, each of which contained potassium sorbate (0.014 mg) as well as tripotassium EDTA (10.5 mg) and propyl gallate (final concentration, 50 /AM). LDL was prepared as described by Havel et al 22 by centrifugation of plasma in a KBr/ NaCl solution at a density of 1.019 g/ml. The middle layer was then recentrifuged at a density of 1.063 g/ml, and the top layer containing LDL was removed. Lipids were extracted from rabbit aortas and LDL with chloroform/methanol containing 5£-cholestan3a-ol (16 /ig, Sigma) as an internal standard. The lipid extract was subjected to transmethylation by treatment with 0.3N sodium methoxide at 60°C for 30 minutes. Cholesterol was measured by gas chromatography on a Varian Model 3300 instrument (Sunnyvale, Calif.) equipped with a flame ionization detector using a DB-23 capillary column (0.25 mmx30 m, J & W Scientific, Folsom, Calif.).
Statistical Analysis
The statistical significance of differences between groups was determined as described in the legends to the figures. All statistical analyses were performed using SYSTAT (version 4.2, Intelligent Software, Evanston, 111.) for personal computers.
Results
We evaluated prostanoid synthesis by the rabbit aorta with two different methods. The template procedure was used to measure prostanoids synthesized primarily by the cells of the aortic lumen. Since the basal release of prostanoids was quite low under these conditions, exogenous arachidonic acid was added to the medium. 18 To investigate the synthesis of prostanoids by other vascular cells, we also measured the amounts of these products synthesized from endogenous substrates by slices of the aorta and PA.
Effects of Preincubation With Ibuprofen and EDTA on Synthesis of 6-oxo-PGF la
The production of prostanoids by the aorta could be diminished by partial autoinactivation of cyclooxygenase caused by a rapid burst of arachidonic acid (6- 23 We attempted to minimize this problem by perfusing the aorta in situ with medium containing EDTA and the reversible cyclooxygenase inhibitor ibuprofen (10 AM). Tissue sections were then prepared in the same medium and mounted in a template as described above. After the tissue sections were washed several times with calcium-containing medium to remove the ibuprofen and EDTA, the aortic lumen was incubated with arachidonic acid (25 ^-M). Pretreatment of aortas with ibuprofen/EDTA resulted in a decrease in the basal release of 6-oxo-PGF la by the aortic lumen and an approximately twofold increase in the amount of this substance synthesized from exogenous arachidonic acid (25 fiM) added after 40 minutes ( Figure 2B ). The initial burst in the release of 6-oxo-PGF la in the first 10 minutes, which was much greater in nonpretreated aortas, was presum- Time of Cholesterol Diet (weeks) Figure 1. ably due to stimulation caused by mounting the tissue in the template.
Pretreatment with ibuprofen/EDTA had a relatively small effect on the amount of 6-oxo-PGF la initially synthesized from endogenous substrates by slices of aorta (Figure 2A) . However, the synthesis of this substance by nonpretreated aortas virtually ceased after incubation for 20 minutes, whereas it continued almost linearly with time up to 40 minutes after pretreatment with ibuprofen/EDTA (Figure 2A ). It should be noted that in the experiment using the template, depicted in Figure 2B , the medium was changed every 10 minutes, whereas in the experiment performed on aortic slices, the values are the cumulative amounts of released 6-oxo-PGF la , measured in aliquots removed from the incubation mixture every 10 minutes.
Biosynthesis of Prostaglandins and Thromboxane B 2 by Blood Vessels From Hypercholesterolemic Rabbits
The amounts of 6-oxo-PGF 1<D TxB 2 , and PGEj formed from endogenous substrates by slices of aortic arch (S]) from rabbits fed cholesterol and peanut oil for different periods of time are shown in Figure  3 (panels A, C, and E). Figure 3 ( Figure 1 .
the luminal surface of the thoracic aorta (T,) as evaluated by the template technique. In both cases, aortas were prepared in medium containing ibuprofen and EDTA as described above. We also examined the synthesis of these three prostanoids by different parts of the aorta and by the PA as shown in Figures 4A, 4C , and 4E (slices) and 4B, 4D, and 4F (luminal surface).
Synthesis of 6-oxo-PGF, a
The amounts of 6-oxo-PGF la (i.e., PGI 2 ) synthesized by slices of the aortic arch ( Figure 3A) and by luminal surfaces of aorta ( Figure 3B ) were almost the same for control and hypercholesterolemic rabbits at all time points investigated. Neither were there any differences between the control and cholesterol-fed groups in the ability of slices ( Figure 4A ) or the lumen ( Figure 4B ) from the lower part of the aorta (S2 and T 2 ) to synthesize this product. Although slices of PA released about four times as much 6-oxo-PGF la compared with slices from the aortic arch, there were no differences between the two groups of animals.
Synthesis of Thromboxane B 2
In contrast to the results with 6-oxo-PGF la , the release of TXB2 by slices of aortic arch (Si) from the group fed cholesterol and peanut oil was significantly greater than from the control group (/?<0.01). This difference was the most dramatic after 15 weeks, when aortas from the experimental group produced Cholesterol (mg/g tissue) about 10 times more TxB2 compared with controls (p<0.01) ( Figure 3C ). TxBz synthesis by the aortic lumen was also significantly higher in the group fed cholesterol and peanut oil (p<0.05), but the difference (~ twofold after 8 and 15 weeks) was much less than with slices. As shown in Figure 4B , slices from the lower part of aortas (S2) from cholesterol-fed rabbits also released significantly more TXB2 than did controls, but the difference was much less pronounced than that observed for the aortic arch. This could be due to the finding that the coverage of the lower part of the aorta by lesions (53%) was considerably less than that of the aortic arch (94%). These results suggest that there may be a correlation between TxB 2 production and the extent of atherosclerotic lesions, which should be related to aortic cholesterol content. We therefore compared the amounts of TXB2 released by slices of aorta with their cholesterol content after 8 and 15 weeks on the experimental diet. Figure 5 clearly shows that there is a positive correlation between these two parameters (r=0.82), suggesting that the excessive amounts of TxB 2 produced by atherosclerotic aorta may have been derived from cells within the lesions.
The PA released more TXB2 than did the aortic arch in control rabbits, but TxB 2 release was not significantly higher in hypercholesterolemic rabbits. There were no differences in TxE$2 synthesis by the lumen of the lower part of the aorta (T 2 ) between the control and experimental groups ( Figure 4D ).
Synthesis of Frostaglandin E 2
PGEz synthesis by aortic slices and the aortic lumen tended to increase with age but was nearly the same in the two groups of animals ( Figures 3C and 3F) . Although the release of PGE2 by slices of the PA was about six times higher than by slices of the aortic arch in control rabbits ( Figure 4F ), there were no differences in its production by blood vessels from control and cholesterol-fed animals ( Figures 4C and 4F) .
Biosynthesis of Prostacyclin and Thromboxane B 2 In Vivo by Control and Cholesterol-Fed Rabbits
To estimate the production of PGI 2 and TxA 2 in vivo, we measured the amounts of their principal urinary metabolites, 2,3-dinor-6-oxo-PGF la and 2,3-dinorTxl^, in rabbits fed control diets or diets enriched in cholesterol and peanut oil ( Figure 6 ). There were no significant differences in the amounts of urinary 2,3-dinor-6-oxo-PGF la between hypercholesterolemic rabbits and controls after 2, 8, and 15 weeks ( Figure 6A ). Somewhat unexpectedly, the levels of 2,3-dinor-TxB2 in urine were the same for controls and cholesterol-fed rabbits after 15 weeks ( Figure 6B ).
Discussion
The major metabolite of arachidonic acid released by both slices and luminal surfaces of rabbit aorta was PGI 2 , which was measured as its stable degradation product, 6-oxo-PGF la . The amounts of 6-oxo-PGF la synthesized by blood vessels from hypercholesterolemic and control rabbits were virtually identical, irrespective of the length of time on the diet and whether we measured its synthesis by tissue slices or the aortic lumen. This was also true for both the upper and lower sections of the thoracic aorta, despite the fact that the upper section (S^ was almost completely covered with lesions.
These results are not in accord with a number of reports in the literature on vascular PGI 2 synthesis in hypercholesterolemic rabbits. The synthesis of PGI 2 by slices of aorta, measured using a bioassay, was reported to be reduced by about 80% in rabbits fed a diet supplemented with cholesterol for 4 weeks. 6 PGI 2 synthesis remained at this level for up to 13 weeks but subsequently increased, so that it was only about 35% lower than in controls after 22 weeks on the diet. 6 Similar results were recently reported by another group that used radioimmunoasoay to measure 6-oxo-PGF la production by aortic slices from rabbits fed a cholesterol-supplemented diet for 9 weeks followed by a normal diet for an additional 5 weeks. 7 In a slightly different model, diet-induced hypercholesterolemia was shown to prevent the recovery of PGI 2 synthesis by rabbit aortas after removal of the endothelium with a balloon catheter. tured smooth muscle cells from cholesterol-fed rabbits were reported to produce less PGI 2 from exogenous arachidonic acid compared with corresponding cells from control rabbits. 25 Cholesterol enrichment of normal rabbit arterial smooth muscle cells has also recently been shown to result in a reduction in the synthesis of 6-oxo-PGF,,,. 26 In contrast to the above studies, a number of other groups have reported modest increases in PGI 2 synthesis by homogenates 13 and slices 14 of aortas from cholesterol-fed rabbits as well as by aortic slices from cholesterol-fed rabbits whose aortas had been subjected to de-endothelialization. 15 The reason for the discrepancy between our results and those described above is not clear, but the experimental protocol we used was somewhat different from those used in the above studies, most of which 6 -81415 used only tissue slices. In our study, we attempted to minimize autoinactivation of cyclooxygenase caused by manipulation of the aorta before incubation by pretreatment with ibuprofen and EDTA. Thus, our results should more accurately reflect the ability of the aorta to synthesize PGI 2 in vivo.
The absence of a reduction in PGI 2 synthesis in hypercholesterolemic rabbits was confirmed by measurement of its urinary metabolite, 2,3-dinor-6-oxo-PGF la , the levels of which were the same in the control and experimental groups. To our knowledge, this is the first report on the urinary levels of this substance in hypercholesterolemic rabbits. In vivo production of PGI 2 has been reported to be higher in atherosclerotic humans than in healthy control subjects on the basis of measurement of urinary 2,3-dinor-6-oxo-PGF 1<r 12 This may be due to an increase in platelet-vessel wall interactions in atherosclerotic subjects, as suggested by the substantial increases in the excretion of 2,3-dinor-TxB2 in these individuals. 27 In contrast, there was no evidence for increased platelet production of Txf$2 in vivo in the hypercholesterolemic rabbit model used in this study, as indicated by the urinary levels of 2,3-dinor-TxB 2 ( Figure 6B) .
The most dramatic change in prostanoid synthesis observed in our study was in TxB 2 formation, which was about 10 times higher in slices from the aortic arch (S,) of hypercholesterolemic rabbits compared with controls after 15 weeks ( Figure 3B ). There was also a large increase in the release of TxB2 by slices from the lower part of the thoracic aorta (S 2 ), but the difference was less than that in the aortic arch ( Figure 4B ). The amount of released TxB 2 appeared to be correlated with the degree of coverage by aortic lesions. More than 90% of the aortic arch of rabbits fed a cholesterol-supplemented diet for 15 weeks was covered with lesions, whereas about 53% of the lower part of the aortas (S 2 ) was covered. Similarly, about 56% of the aortic arch of cholesterol-fed rabbits was covered with lesions after 8 weeks. The relation between aortic TXB2 production and atherosclerotic lesions was further supported by the strong correlation between aortic cholesterol content and TxB 2 release ( Figure 5 ). Although TxB 2 synthesis by slices of PA from control rabbits was about three times higher than by the aortic arch, we did not detect the high levels of TxB2 synthesis reported earlier for this tissue. 28 TxB 2 release by the PA appeared to be elevated in hypercholesterolemic rabbits, but the difference was not significant.
In contrast to aortic slices, the differences between TxB 2 formation by the luminal surface of aortas from control and hypercholesterolemic rabbits were relatively modest, suggesting that the major site of increased TxB2 synthesis in aortas from hypercholesterolemic rabbits is not the endothelium, but rather the underlying cells. Atherosclerotic lesions from hypercholesterolemic rabbits are known to contain foam cells derived from both smooth muscle cells and macrophages. 29 Both intravascular macrophages 30 and rabbit circulating monocytes 31 have been reported to synthesize substantial amounts of TxB^ Thus, either macrophages or macrophage-derived foam cells could be a likely source of the TxB2 synthesized by aortas from atherosclerotic rabbits.
Modest increases (=30-200% above control values) in the production of TxB2 by whole aortas 1 ' or aortic slices 7 from hypercholesterolemic rabbits have recently been reported in the literature. Production of TxB 2 from exogenous arachidonic acid by slices of de-endothelialized aortas from hypercholesterolemic rabbits was also recently reported to be about 70% higher after 30 minutes than in controls. 15 Production of TxB 2 by different regions of the aorta or by the luminal surface was not reported in the above studies.
An inhibitor of thromboxane synthase has been shown to reduce the area of the aorta covered by atherosclerotic lesions in cholesterol-fed rabbits. 32 The large increase in TxB 2 synthesis by the aortic arch that we observed raises the possibility that aortic TxA 2 could be involved in the development of atherosclerosis due to its potent effects on platelets. However, it must be kept in mind that TxA 2 production by blood vessels, even in atherosclerosis, would be much less than by platelets, the major site of its production. We did not observe any significant differences in the excretion of the urinary TxA 2 metabolite, 2,3-dinorTxB2, between control and cholesterol-fed rabbits, suggesting that in this model there are not large alterations in TxA 2 production by platelets in vivo. This is in contrast to human studies in which the in vivo production of TxA 2 was shown to be considerably elevated in atherosclerotic patients. 27 
